Literature DB >> 15531626

Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.

Nefyn H Williams1, Rhiannon T Edwards, Pat Linck, Rachel Muntz, Richard Hibbs, Clare Wilkinson, Ian Russell, Daphne Russell, Barry Hounsome.   

Abstract

BACKGROUND: Spinal pain is common and costly to health services and society. Management guidelines have encouraged primary care referral for spinal manipulation, but the evidence base is weak. More economic evaluations alongside pragmatic trials have been recommended.
OBJECTIVE: Our aim was to assess the cost-utility of a practice-based osteopathy clinic for subacute spinal pain.
METHODS: A cost-utility analysis was performed alongside a pragmatic single-centre randomized controlled trial in a primary care osteopathy clinic accepting referrals from 14 neighbouring practices in North West Wales. Patients with back pain of 2-12 weeks duration were randomly allocated to treatment with osteopathy plus usual GP care or usual GP care alone. Costs were measured from a National Health Service (NHS) perspective. All primary and secondary health care interventions recorded in GP notes were collected for the study period. We calculated quality adjusted life year (QALY) gains based on EQ-5D responses from patients in the trial, and then cost per QALY ratios. Confidence intervals (CIs) were estimated using non-parametric bootstrapping.
RESULTS: Osteopathy plus usual GP care was more effective but resulted in more health care costs than usual GP care alone. The point estimate of the incremental cost per QALY ratio was 3560 pounds (80% CI 542 pounds-77,100 pounds). Sensitivity analysis examining spine-related costs alone and total costs excluding outliers resulted in lower cost per QALY ratios.
CONCLUSION: A primary care osteopathy clinic may be a cost-effective addition to usual GP care, but this conclusion was subject to considerable random error. Rigorous multi-centre studies are needed to assess the generalizability of this approach.

Entities:  

Mesh:

Year:  2004        PMID: 15531626     DOI: 10.1093/fampra/cmh612

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  14 in total

Review 1.  Cost effectiveness of complementary treatments in the United Kingdom: systematic review.

Authors:  Peter H Canter; Joanna Thompson Coon; Edzard Ernst
Journal:  BMJ       Date:  2005-10-15

2.  The social tariff of EQ-5D is not adequate to assess quality of life in patients with low back pain.

Authors:  Javier Zamora; Francisco Kovacs; Víctor Abraira; Carmen Fernández; Pablo Lázaro
Journal:  Qual Life Res       Date:  2006-11-17       Impact factor: 4.147

Review 3.  Taking responsibility for the early assessment and treatment of patients with musculoskeletal pain: a review and critical analysis.

Authors:  Nadine E Foster; Jan Hartvigsen; Peter R Croft
Journal:  Arthritis Res Ther       Date:  2012-02-29       Impact factor: 5.156

4.  Effects of tailored neck-shoulder pain treatment based on a decision model guided by clinical assessments and standardized functional tests. A study protocol of a randomized controlled trial.

Authors:  Martin Björklund; Mats Djupsjöbacka; Asa Svedmark; Charlotte Häger
Journal:  BMC Musculoskelet Disord       Date:  2012-05-20       Impact factor: 2.362

5.  Cost-effectiveness of complementary therapies in the United kingdom-a systematic review.

Authors:  Peter H Canter; Joanna Thompson Coon; Edzard Ernst
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-26       Impact factor: 2.629

6.  Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature.

Authors:  Dominic Thorrington; Ken Eames
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

7.  Economic evaluation alongside pragmatic randomised trials: developing a standard operating procedure for clinical trials units.

Authors:  Rhiannon T Edwards; Barry Hounsome; Pat Linck; Ian T Russell
Journal:  Trials       Date:  2008-11-17       Impact factor: 2.279

8.  Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations.

Authors:  Patricia M Herman; Beth L Poindexter; Claudia M Witt; David M Eisenberg
Journal:  BMJ Open       Date:  2012-09-03       Impact factor: 2.692

9.  Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial.

Authors:  Paolo Zanaboni; Maurizio Landolina; Maurizio Marzegalli; Maurizio Lunati; Giovanni B Perego; Giuseppe Guenzati; Antonio Curnis; Sergio Valsecchi; Francesca Borghetti; Gabriella Borghi; Cristina Masella
Journal:  J Med Internet Res       Date:  2013-05-30       Impact factor: 5.428

Review 10.  The impact of NHS based primary care complementary therapy services on health outcomes and NHS costs: a review of service audits and evaluations.

Authors:  Lesley Wye; Deborah Sharp; Alison Shaw
Journal:  BMC Complement Altern Med       Date:  2009-03-06       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.